Recombinant Human BTN3A2 Protein
Beta LifeScience
SKU/CAT #: BLK-02636P-100UG
Human BTN3A2 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human BTN3A2 Protein
Beta LifeScience
SKU/CAT #: BLK-02636P-100UG
Collections: Others immune checkpoint proteins, Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human BTN3A2 Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Gln30-Trp248. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | P78410 |
Target Symbol | BTN3A2 |
Synonyms | BT3.2; BTF3; BTF4; BT3.3; BTN3A2; FLJ40011; BTN3.2; CD277 |
Species | Human |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Gln30-Trp248 |
Mol. Weight | The protein has a predicted MW of 26.5 kDa. Due to glycosylation, the protein migrates to 27-33 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC).In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206 /CD68 expression is associated with high risk of disease progression. |